BIB

Ultra Nasdaq Biotechnology

BIB seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology® Index.

How to Buy
Why BIB?
Target Magnified Returns

BIB is the only ETF that targets 2x the daily returns of the Biotechnology industry.

Efficient

BIB offers 2x exposure with less cash.

Convenience

Buy and sell leveraged exposure via a single ticker in a brokerage account.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”).

While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target.

The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB NAV -7.55% 2.21% 37.13% 2.21% 70.94% 15.59% 0.06% 7.43% 16.31% 04/07/2010
BIB Market Price -7.52% 2.18% 37.06% 2.18% 70.63% 15.62% 0.04% 7.44% 16.31% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Net Assets
    $83,519,002
  • Gross Expense Ratio
    1.19%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 4/09/2026
  • NAV
    $84.36
  • NAV Change
    $+0.63 up caret
  • Market Price
    $84.36
  • Market Price Change
    $+0.70 up caret
  • Trading Volume (M)
    4,696
  • View Premium / Discount
Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Net Assets
    $83,519,002
  • Gross Expense Ratio
    1.19%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 4/09/2026
  • NAV
    $84.36
  • NAV Change
    $+0.63 up caret
  • Market Price
    $84.36
  • Market Price Change
    $+0.70 up caret
  • Trading Volume (M)
    4,696
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2026. Without the fee waiver performance would likely be lower.

Exposures

Index as of 12/31/2025

Holdings

as of 4/09/2026

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
5.21% GILD GILEAD SCIENCES INC -- $4,261,705.37 29,993 2369174
5.00% AMGN AMGEN INC -- $4,092,956.00 11,510 2023607
4.91% VRTX VERTEX PHARMACEUTICALS INC -- $4,016,998.98 8,991 2931034
4.23% REGN REGENERON PHARMACEUTICALS -- $3,462,235.65 4,509 2730190
2.26% ALNY ALNYLAM PHARMACEUTICALS INC -- $1,849,287.68 5,756 B00FWN1
1.83% INSM INSMED INC -- $1,493,443.22 9,358 2614487
1.38% BIIB BIOGEN INC -- $1,128,190.70 6,370 2455965
1.34% UTHR UNITED THERAPEUTICS CORP -- $1,093,212.54 1,902 2430412
1.20% ARGX ARGENX SE - ADR -- $985,415.50 1,231 BDVLM39
1.10% RPRX ROYALTY PHARMA PLC- CL A -- $898,331.70 18,599 BMVP7Y0
1.08% ROIV ROIVANT SCIENCES LTD -- $884,959.04 31,073 BMW4NZ9
1.07% MRNA MODERNA INC -- $879,195.60 17,145 BGSXTS3
1.02% INCY INCYTE CORP -- $837,734.40 8,640 2471950
1.01% RVMD REVOLUTION MEDICINES INC -- $827,780.66 8,603 BL71K91
1.00% ILMN ILLUMINA INC -- $821,045.13 6,639 2613990
0.83% VTRS VIATRIS INC -- $680,323.07 49,987 BMWS3X9
0.79% SMMT SUMMIT THERAPEUTICS INC -- $650,013.22 33,662 BMTVQS7
0.79% ASND ASCENDIS PHARMA A/S - ADR -- $645,849.12 2,672 BV9G6B8
0.78% BBIO BRIDGEBIO PHARMA INC -- $635,651.84 8,417 BK1KWG8
0.75% MEDP MEDPACE HOLDINGS INC -- $617,346.50 1,231 BDCBC61
0.70% NBIX NEUROCRINE BIOSCIENCES INC -- $573,687.12 4,358 2623911
0.67% IONS IONIS PHARMACEUTICALS INC -- $548,155.96 7,172 BDJ0LS6
0.65% JAZZ JAZZ PHARMACEUTICALS PLC -- $529,430.08 2,672 B4Q5ZN4
0.64% MDGL MADRIGAL PHARMACEUTICALS INC -- $522,727.10 997 BD59BS7
0.63% EXEL EXELIXIS INC -- $511,997.75 11,275 2576941
0.61% SNY SANOFI-ADR -- $500,225.00 10,625 2964557
0.61% GH GUARDANT HEALTH INC -- $496,258.81 5,693 BFXC911
0.57% BMRN BIOMARIN PHARMACEUTICAL INC -- $470,105.00 8,350 2437071
0.56% BNTX BIONTECH SE-ADR -- $454,933.08 4,946 BK6H543
0.53% ONC BEONE MEDICINES LTD-ADR -- $435,026.96 1,388 BYYWPW6
0.49% ARWR ARROWHEAD PHARMACEUTICALS IN -- $402,744.63 6,081 BYQBFJ8
0.49% AXSM AXSOME THERAPEUTICS INC -- $397,336.90 2,221 BYZR4X4
0.47% PRAX PRAXIS PRECISION MEDICINES I -- $387,170.16 1,209 BQ721R4
0.47% PCVX VAXCYTE INC -- $385,439.12 6,248 BKPVGH6
0.42% CYTK CYTOKINETICS INC -- $345,362.73 5,347 BBBSBJ5
0.42% HALO HALOZYME THERAPEUTICS INC -- $343,717.92 5,124 2975098
0.41% ABVX ABIVAX SA-ADR -- $335,089.54 2,666 BLC89B2
0.41% IBRX IMMUNITYBIO INC -- $333,869.80 44,635 BNSP0B8
0.41% TEM TEMPUS AI INC-CL A -- $333,010.56 7,541 BSLSJJ0
0.41% NUVL NUVALENT INC-A -- $332,387.02 3,178 BMVBZD3
0.40% KRYS KRYSTAL BIOTECH INC -- $328,337.43 1,271 BD6JX35
0.38% KYMR KYMERA THERAPEUTICS INC -- $309,481.05 3,543 BMPRZV5
0.35% PTGX PROTAGONIST THERAPEUTICS INC -- $288,419.54 2,771 BDCBCD8
0.32% COGT COGENT BIOSCIENCES INC -- $263,205.45 7,047 BLR6XK8
0.32% MIRM MIRUM PHARMACEUTICALS INC -- $259,150.05 2,619 BJDX8Y8
0.31% RYTM RHYTHM PHARMACEUTICALS INC -- $255,375.45 2,965 BF2YWG4
0.31% PTCT PTC THERAPEUTICS INC -- $254,564.05 3,593 B17VCN9
0.31% ALKS ALKERMES PLC -- $252,646.20 7,235 B3P6D26
0.31% CGON CG ONCOLOGY INC -- $251,340.96 3,666 BRBCSP4
0.30% TERN TERNS PHARMACEUTICALS INC -- $242,669.52 4,617 BMDJ0C9
0.29% CAI CARIS LIFE SCIENCES INC -- $235,200.00 12,250 BT18HP9
0.29% ERAS ERASCA INC -- $233,353.12 13,442 BNLYBF3
0.28% IMVT IMMUNOVANT INC -- $226,694.70 8,838 BJRFSB7
0.28% APLS APELLIS PHARMACEUTICALS INC -- $225,607.50 5,550 BYTQ6X1
0.27% SRRK SCHOLAR ROCK HOLDING CORP -- $217,911.70 4,430 BFZQ0L8
0.26% CRSP CRISPR THERAPEUTICS AG -- $215,517.24 4,167 BDHF4K6
0.26% XENE XENON PHARMACEUTICALS INC -- $211,627.08 3,612 BRJ3GY4
0.25% CNTA CENTESSA PHARMACEUTICALS-ADR -- $206,473.68 5,193 BLB0YQ9
0.25% APGE APOGEE THERAPEUTICS INC -- $205,917.60 2,380 BM9HHL5
0.23% GPCR STRUCTURE THERAPEUTICS INC -- $186,538.62 3,383 BQS9486
0.22% CRNX CRINETICS PHARMACEUTICALS IN -- $180,157.98 4,546 BDD19F8
0.22% LGND LIGAND PHARMACEUTICALS -- $177,878.60 865 2501578
0.22% SYRE SPYRE THERAPEUTICS INC -- $176,483.93 3,409 BQBBDY8
0.21% INDV INDIVIOR PHARMACEUTICALS INC -- $175,378.68 5,428 BTZRLN8
0.21% -- NEWAMSTERDAM PHARMA CO NV -- $174,999.30 4,990 BP8JSP4
0.21% AMRX AMNEAL PHARMACEUTICALS INC -- $174,848.00 13,660 BFNF1D6
0.20% ACAD ACADIA PHARMACEUTICALS INC -- $167,018.00 7,400 2713317
0.19% EWTX EDGEWISE THERAPEUTICS INC -- $156,069.12 4,656 BKY5JZ8
0.17% DYN DYNE THERAPEUTICS INC -- $138,365.92 7,147 BN15WD1
0.16% TARS TARSUS PHARMACEUTICALS INC -- $133,768.98 1,847 BMH5RL1
0.16% ORKA ORUKA THERAPEUTICS INC -- $133,623.60 2,101 BKVF0J2
0.16% DNLI DENALI THERAPEUTICS INC -- $132,811.65 6,885 BD2B4V0
0.16% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $132,186.60 5,380 BKX9VD3
0.16% TWST TWIST BIOSCIENCE CORP -- $130,012.08 2,662 BGKG6G7
0.16% SUPN SUPERNUS PHARMACEUTICALS INC -- $128,183.50 2,489 B72ZBG4
0.15% VERA VERA THERAPEUTICS INC -- $126,801.14 3,098 BL55460
0.15% ALMS ALUMIS INC -- $125,917.66 5,489 BPLQG36
0.15% TVTX TRAVERE THERAPEUTICS INC -- $125,917.20 4,005 BLFGJD5
0.15% TNGX TANGO THERAPEUTICS INC -- $121,032.90 5,847 BP2P6L0
0.14% IDYA IDEAYA BIOSCIENCES INC -- $118,203.00 3,813 BK0VHF6
0.14% ELVN ENLIVEN THERAPEUTICS INC -- $117,531.02 2,578 BMFD115
0.14% TXG 10X GENOMICS INC-CLASS A -- $117,484.00 5,108 BKS3RS7
0.14% BEAM BEAM THERAPEUTICS INC -- $116,457.59 4,423 BK6L288
0.14% RLAY RELAY THERAPEUTICS INC -- $116,385.00 7,759 BN2R582
0.14% KOD KODIAK SCIENCES INC -- $112,254.00 2,650 BFXC933
0.14% IRON DISC MEDICINE INC -- $111,516.10 1,657 BMGJZJ8
0.13% VCYT VERACYTE INC -- $108,188.85 3,451 BFTWZY0
0.13% BCRX BIOCRYST PHARMACEUTICALS INC -- $107,702.10 10,890 2100362
0.13% ADMA ADMA BIOLOGICS INC -- $102,779.60 10,340 B9NSBM2
0.12% SRPT SAREPTA THERAPEUTICS INC -- $101,146.50 4,550 B8DPDT7
0.12% RARE ULTRAGENYX PHARMACEUTICAL IN -- $100,302.45 4,195 BJ62Z18
0.12% DAWN DAY ONE BIOPHARMACEUTICALS I -- $96,337.80 4,485 BLB0YH0
0.12% SNDX SYNDAX PHARMACEUTICALS INC -- $94,806.04 3,829 BN7Q7R7
0.12% KNSA KINIKSA PHARMACEUTICALS INTE -- $94,328.69 1,993 BRXB0C0
0.11% MLYS MINERALYS THERAPEUTICS INC -- $93,356.12 3,436 BP9N0G0
0.11% DFTX DEFINIUM THERAPEUTICS INC -- $92,705.76 4,328 BV2DHY6
0.11% AUPH AURINIA PHARMACEUTICALS INC -- $92,121.12 5,772 BFWLC09
0.11% ADPT ADAPTIVE BIOTECHNOLOGIES -- $89,565.60 6,684 BJ5FZ74
0.11% ZYME ZYMEWORKS INC -- $88,887.50 3,250 BPCQZY9
0.11% OCUL OCULAR THERAPEUTIX INC -- $87,894.30 9,451 BNZB1X8
0.11% STOK STOKE THERAPEUTICS INC -- $87,136.85 2,479 BJQ05Z6
0.10% TYRA TYRA BIOSCIENCES INC -- $85,010.73 2,317 BMVNDH9
0.10% AGIO AGIOS PHARMACEUTICALS INC -- $83,715.56 2,543 BCBVTX1
0.10% AMLX AMYLYX PHARMACEUTICALS INC -- $82,599.08 4,769 BPCK358
0.10% ANAB ANAPTYSBIO INC -- $82,522.16 1,204 BDRW1L7
0.10% GRAL GRAIL INC -- $80,423.96 1,691 BSLSSX7
0.10% GMAB GENMAB A/S -SP ADR -- $79,042.60 2,795 BBC9WC7
0.10% ANIP ANI PHARMACEUTICALS INC -- $77,976.22 973 BCDWBX6
0.10% INVA INNOVIVA INC -- $77,803.00 3,215 BDDXF67
0.09% SION SIONNA THERAPEUTICS INC -- $75,407.71 1,939 BQKXDX4
0.09% PHVS PHARVARIS NV -- $75,308.74 2,782 BMZ2X38
0.09% RXRX RECURSION PHARMACEUTICALS-A -- $75,007.91 22,661 BM9FJ13
0.09% VCEL VERICEL CORP -- $74,065.95 2,205 BSBMN89
0.09% TRVI TREVI THERAPEUTICS INC -- $74,027.80 5,566 BJH9ZN0
0.09% HRMY HARMONY BIOSCIENCES HOLDINGS -- $73,249.92 2,512 BKSGZN7
0.09% NRIX NURIX THERAPEUTICS INC -- $72,495.36 4,464 BMVLGP2
0.09% IOVA IOVANCE BIOTHERAPEUTICS INC -- $71,714.84 17,884 BF0DMK7
0.09% NTLA INTELLIA THERAPEUTICS INC -- $70,920.24 5,128 BYZM6C2
0.09% RAPP RAPPORT THERAPEUTICS INC -- $70,835.40 2,070 BR3T9B6
0.08% VIR VIR BIOTECHNOLOGY INC -- $67,070.09 6,823 BK4PZ38
0.08% LEGN LEGEND BIOTECH CORP-ADR -- $66,684.80 3,664 BMX9K07
0.08% PGEN PRECIGEN INC -- $65,595.74 15,362 BKM5C84
0.08% ARDX ARDELYX INC -- $65,259.98 10,646 BN89V40
0.08% MBX MBX BIOSCIENCES INC -- $64,044.14 1,949 BQXJKH2
0.07% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $60,534.43 1,903 BLCD809
0.07% BCAX BICARA THERAPEUTICS INC -- $60,445.00 2,750 BQB42F1
0.07% NVAX NOVAVAX INC -- $60,394.88 7,072 BJDQXG4
0.07% HROW HARROW INC -- $60,036.90 1,610 BHNDW86
0.07% GLUE MONTE ROSA THERAPEUTICS INC -- $59,763.55 3,311 BP7KZP7
0.07% WVE WAVE LIFE SCIENCES LTD -- $58,518.68 8,173 BYZG9R0
0.07% ATAI ATAIBECKLEY INC -- $58,341.60 15,768 BWJDYK1
0.07% MAZE MAZE THERAPEUTICS INC -- $58,241.32 2,089 BSRK699
0.07% OLMA OLEMA PHARMACEUTICALS INC -- $57,890.56 3,479 BMZ4LN0
0.07% CRVS CORVUS PHARMACEUTICALS INC -- $56,192.62 3,586 BYP80F1
0.07% TSHA TAYSHA GENE THERAPIES INC -- $55,055.33 11,891 BNC1BX1
0.07% NVCR NOVOCURE LTD -- $54,340.00 4,940 BYSS4X4
0.06% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $52,885.55 895 BL95N25
0.06% SVRA SAVARA INC -- $51,861.45 8,835 BYXGN81
0.06% ALVO ALVOTECH SA -- $51,624.00 14,340 BPNTJ34
0.06% EYPT EYEPOINT INC -- $51,142.62 3,594 BMGS7L1
0.06% ZBIO ZENAS BIOPHARMA INC -- $50,327.20 2,365 BQB42H3
0.06% AVBP ARRIVENT BIOPHARMA INC -- $48,859.25 1,793 BMGTLY5
0.06% GERN GERON CORP -- $48,776.64 27,714 2370381
0.06% COLL COLLEGIUM PHARMACEUTICAL INC -- $48,609.75 1,379 BX7RSN3
0.06% SEPN SEPTERNA INC -- $48,244.69 1,943 BQNKXX2
0.06% INBX INHIBRX BIOSCIENCES INC -- $47,798.25 631 BNSP8K3
0.06% ABCL ABCELLERA BIOLOGICS INC -- $45,277.28 13,162 BL53SR3
0.06% ORIC ORIC PHARMACEUTICALS INC -- $45,236.04 4,358 BKVDFF7
0.05% QURE UNIQURE NV -- $44,091.50 2,705 BJFSR88
0.05% KALV KALVISTA PHARMACEUTICALS INC -- $43,790.25 2,195 BD06CS0
0.05% XERS XERIS BIOPHARMA HOLDINGS INC -- $43,296.04 7,204 BLR7H87
0.05% PHAT PHATHOM PHARMACEUTICALS INC -- $43,228.80 3,420 BJLKVS6
0.05% GRFS GRIFOLS SA-ADR -- $42,624.75 5,295 B8K7T65
0.05% PCRX PACIRA BIOSCIENCES INC -- $41,827.92 1,756 B3X26D8
0.05% URGN UROGEN PHARMA LTD -- $41,696.43 2,031 BZ7PJQ1
0.05% GHRS GH RESEARCH PLC -- $41,122.11 2,693 BP6C0S2
0.05% AMPH AMPHASTAR PHARMACEUTICALS IN -- $41,093.03 1,969 BNFWZS4
0.05% XNCR XENCOR INC -- $39,908.05 3,185 BGCYWN8
0.05% CGEM CULLINAN THERAPEUTICS INC -- $39,013.65 2,565 BM90J52
0.05% ANNX ANNEXON INC -- $38,577.62 6,283 BMVV9R5
0.05% JANX JANUX THERAPEUTICS INC -- $38,388.26 2,642 BMFX8Y7
0.05% FTRE FORTREA HOLDINGS INC -- $38,073.42 4,059 BRXYZ57
0.04% OMER OMEROS CORP -- $36,647.07 3,077 B4NB858
0.04% TBPH THERAVANCE BIOPHARMA INC -- $36,426.55 2,201 BMNDK09
0.04% SANA SANA BIOTECHNOLOGY INC -- $36,079.68 11,564 BMFJJ97
0.04% ABUS ARBUTUS BIOPHARMA CORP -- $35,905.00 8,350 BZ0QMB7
0.04% SPRY ARS PHARMACEUTICALS INC -- $35,503.11 4,293 BMCR7V2
0.04% MNKD MANNKIND CORP -- $34,245.12 13,377 BF081J4
0.04% BIOA BIOAGE LABS INC -- $33,551.94 1,886 BT9K6D8
0.04% KURA KURA ONCOLOGY INC -- $33,435.30 3,778 BYZD465
0.04% MESO MESOBLAST LTD- SPON ADR -- $33,057.60 2,272 BQS7491
0.04% MGTX MEIRAGTX HOLDINGS PLC -- $32,633.96 3,494 BFYQFJ2
0.04% ETON ETON PHARMACEUTICALS INC -- $31,517.30 1,163 BGL0JK3
0.04% CTMX CYTOMX THERAPEUTICS INC -- $31,185.20 7,355 BYWVTY5
0.04% ARVN ARVINAS INC -- $31,030.26 2,778 BDZ30Q0
0.04% DSGN DESIGN THERAPEUTICS INC -- $30,875.28 2,472 BMFK3H6
0.04% ZLAB ZAI LAB LTD-ADR -- $30,840.38 1,487 BD9GVY0
0.04% CSTL CASTLE BIOSCIENCES INC -- $30,224.70 1,290 BKLCWZ3
0.03% ALLO ALLOGENE THERAPEUTICS INC -- $28,392.87 9,757 BFZNYB7
0.03% VOR VOR BIOPHARMA INC -- $28,142.40 1,804 BRJJYT3
0.03% PSNL PERSONALIS INC -- $27,666.87 4,543 BJQ0608
0.03% PRME PRIME MEDICINE INC -- $27,507.87 7,837 BPBJFM7
0.03% SLDB SOLID BIOSCIENCES INC -- $27,410.40 3,384 BQHN6C7
0.03% IRWD IRONWOOD PHARMACEUTICALS INC -- $25,437.60 7,066 B3MZ6K5
0.03% TECX TECTONIC THERAPEUTIC INC -- $25,369.44 816 BPBPCG8
0.03% CRMD CORMEDIX INC -- $25,171.20 3,420 BJ0LT31
0.03% PRTA PROTHENA CORP PLC -- $24,714.88 2,336 B91XRN2
0.03% UPB UPSTREAM BIO INC -- $24,445.32 2,346 BRCFFK6
0.03% RIGL RIGEL PHARMACEUTICALS INC -- $24,072.39 789 BQD3J33
0.03% LRMR LARIMAR THERAPEUTICS INC -- $23,989.17 4,713 BMXNGZ6
0.03% KYTX KYVERNA THERAPEUTICS INC -- $23,758.40 2,480 BSMLR16
0.03% ZVRA ZEVRA THERAPEUTICS INC -- $23,721.53 2,443 BLFBZ32
0.03% TRDA ENTRADA THERAPEUTICS INC -- $23,365.15 1,663 BP81RK8
0.03% FULC FULCRUM THERAPEUTICS INC -- $22,867.81 2,891 BJDX8Z9
0.03% CMPS COMPASS PATHWAYS PLC -- $22,855.68 4,096 BMC3HS7
0.03% ESPR ESPERION THERAPEUTICS INC -- $22,624.04 10,378 BBNBTD2
0.03% AQST AQUESTIVE THERAPEUTICS INC -- $22,084.32 5,296 BYVQJ96
0.03% LYEL LYELL IMMUNOPHARMA INC -- $22,013.55 923 BTNMG41
0.03% FDMT 4D MOLECULAR THERAPEUTICS IN -- $21,785.76 2,214 BKLXFX5
0.03% IVVD INVIVYD INC -- $21,413.40 12,030 BM8NHS1
0.03% ACRS ACLARIS THERAPEUTICS INC -- $21,358.80 5,235 BYV2W40
0.03% KMDA KAMADA LTD -- $21,317.55 2,505 B2Q9833
0.03% REPL REPLIMUNE GROUP INC -- $21,193.26 3,586 BDDVW37
0.02% LXEO LEXEO THERAPEUTICS INC -- $20,376.67 3,169 BQ6C357
0.02% AVIR ATEA PHARMACEUTICALS INC -- $19,803.44 3,391 BLN9Z50
0.02% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $19,764.05 6,355 BMCWKZ2
0.02% RGNX REGENXBIO INC -- $19,694.08 2,198 BZ0G875
0.02% ABSI ABSCI CORP -- $19,257.60 6,528 BN94K69
0.02% VNDA VANDA PHARMACEUTICALS INC -- $18,882.08 2,576 B12W3P6
0.02% AURA AURA BIOSCIENCES INC -- $18,692.46 2,757 BP81R42
0.02% GLPG GALAPAGOS NV-SPON ADR -- $18,392.64 644 B292NQ7
0.02% ALT ALTIMMUNE INC -- $18,373.68 5,436 BFY7DC4
0.02% PACB PACIFIC BIOSCIENCES OF CALIF -- $17,699.85 13,111 B4N8MH9
0.02% ENTA ENANTA PHARMACEUTICALS INC -- $17,590.95 1,261 B9L5200
0.02% PBYI PUMA BIOTECHNOLOGY INC -- $17,222.40 2,208 B7F2TY6
0.02% RCKT ROCKET PHARMACEUTICALS INC -- $16,970.40 4,714 BDFKQ07
0.02% CTNM CONTINEUM THERAPEUTICS INC-A -- $16,961.26 1,322 BPRBTY7
0.02% KROS KEROS THERAPEUTICS INC -- $16,524.27 1,323 BM7V485
0.02% IMRX IMMUNEERING CORP - CLASS A -- $15,757.44 2,784 BMVBZF5
0.02% CADL CANDEL THERAPEUTICS INC -- $15,235.20 3,174 BP0TQC5
0.02% NMRA NEUMORA THERAPEUTICS INC -- $15,090.40 7,255 BN4JN37
0.02% ACIU AC IMMUNE SA -- $14,854.60 4,369 BZC0D70
0.02% NGNE NEUROGENE INC -- $14,360.64 672 BS2F741
0.02% SIGA SIGA TECHNOLOGIES INC -- $13,684.00 3,110 2107437
0.02% CABA CABALETTA BIO INC -- $13,244.26 4,178 BK5MWR1
0.02% AUTL AUTOLUS THERAPEUTICS PLC -- $12,802.23 8,709 BFMLGR4
0.02% LENZ LENZ THERAPEUTICS INC -- $12,606.53 1,357 BQV0J03
0.01% AVXL ANAVEX LIFE SCIENCES CORP -- $12,273.20 4,024 BYTYP72
0.01% EDIT EDITAS MEDICINE INC -- $12,247.82 4,238 BZ8FPH3
0.01% FHTX FOGHORN THERAPEUTICS INC -- $12,176.18 2,542 BMF7DT9
0.01% CCCC C4 THERAPEUTICS INC -- $11,987.88 4,236 BKX9NQ0
0.01% EOLS EVOLUS INC -- $11,927.12 2,813 BDRJH21
0.01% NBP NOVABRIDGE BIOSCIENCES -- $11,841.39 4,873 BKRRKY7
0.01% SLN SILENCE THERAPEUTICS PLC-ADR -- $11,820.40 2,038 BL5B6Z1
0.01% CHRS COHERUS ONCOLOGY INC -- $10,706.85 6,489 BRK0149
0.01% OBIO ORCHESTRA BIOMED HOLDINGS IN -- $10,367.73 2,451 BPRB2N7
0.01% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $10,135.26 1,233 BKC9SX3
0.01% VYGR VOYAGER THERAPEUTICS INC -- $10,133.64 2,559 BY7RB53
0.01% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $9,994.67 2,011 BKDQKM6
0.01% CDXS CODEXIS INC -- $9,410.40 3,921 B5LL2C2
0.01% OABI OMNIAB INC -- $9,373.50 6,249 BN13S71
0.01% MENS JYONG BIOTECH LTD -- $8,634.96 3,222 BPTK6Z2
0.01% CRBU CARIBOU BIOSCIENCES INC -- $7,951.72 4,057 BNYJR68
0.01% LFCR LIFECORE BIOMEDICAL INC -- $7,670.00 1,625 2517058
0.01% SGMT SAGIMET BIOSCIENCES INC-A -- $7,591.44 1,346 BP2NYN2
0.01% TNYA TENAYA THERAPEUTICS INC -- $6,963.40 9,410 BNNXX52
0.01% TKNO ALPHA TEKNOVA INC -- $6,483.96 2,324 BP7L561
0.01% BDTX BLACK DIAMOND THERAPEUTICS I -- $6,380.34 2,473 BKTV702
0.01% QSI QUANTUM-SI INC -- $6,336.70 8,484 BNR5QT9
0.01% HUMA HUMACYTE INC -- $5,086.05 8,379 BMYTJP4
0.01% PEPG PEPGEN INC -- $4,807.46 2,986 BMTX3D7
0.01% PYXS PYXIS ONCOLOGY INC -- $4,353.44 2,704 BLBR8D5
-- GOSS GOSSAMER BIO INC -- $3,733.84 10,048 BJ0CK86
-- AARD AARDVARK THERAPEUTICS INC -- $3,685.50 945 BTXQTX3
-- RANI RANI THERAPEUTICS HOLDINGS-A -- $3,303.30 4,235 BNNXX18
-- STRO SUTRO BIOPHARMA INC -- $26.76 01 BTFHQP5
-- THRD THIRD HARMONIC BIO INC -- $00.00 1,662 BNNPQY8
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $00.00 9,785 BM9HFX3
37.88% -- NASDAQ BIO INDEX SWAP BNP PARIBAS 30,995,977 -- 5,213 --
30.02% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 24,568,459 -- 4,132 --
26.90% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 22,011,722 -- 3,702 --
19.18% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 15,691,230 -- 2,639 --
14.46% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 11,832,341 -- 1,990 --
4.60% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 3,763,755 -- 633 --
-- -- NET OTHER ASSETS (LIABILITIES) -- $27,146,300.48 27,146,300 --

Index

as of 12/31/2025

  • Total Number of Companies262
  • Price/Book Ratio3.78
  • Dividend Yield ( % )0.85
  • Avg. Index Market Capitalization$7.32 billion
About the Index

The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.